Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates-Reply

Affiliations

Comment

John H McDermott et al. JAMA Pediatr. 2022.

. 2022 Aug 1;176(8):827-828.

doi: 10.1001/jamapediatrics.2022.2062.

¹ Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.

No abstract available

Comment on

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.
McDermott JH, Mahaveer A, James RA, Booth N, Turner M, Harvey KE, Miele G, Beaman GM, Stoddard DC, Tricker K, Corry RJ, Garlick J, Ainsworth S, Beevers T, Bruce IA, Body R, Ulph F, MacLeod R, Roberts PL, Wilson PM, Newman WG; PALOH Study Team. McDermott JH, et al. JAMA Pediatr. 2022 May 1;176(5):486-492. doi: 10.1001/jamapediatrics.2022.0187. JAMA Pediatr. 2022. PMID: 35311942 Free PMC article.
Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates.
Muñoz Mahmood M, Leung RK. Muñoz Mahmood M, et al. JAMA Pediatr. 2022 Aug 1;176(8):828. doi: 10.1001/jamapediatrics.2022.2065. JAMA Pediatr. 2022. PMID: 35727587 No abstract available.